NVCT: Nuvectis Pharma Inc
NVCT exchange rate has changed by -2.42% for today. During the day, the instrument was traded at a low of 20.29 and at a high of 22.23.
Follow Nuvectis Pharma Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVCT News
- HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $39 Price Target
- Nuvectis Pharma's NXP200 BRAF Inhibitor Receives China's Breakthrough Therapy Designation
- Nuvectis Pharma:Haisco Licensing Deal Revitalises Biotech, But No Rush To Invest Now(NVCT)
- This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mond
- Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
- Wall Street Analysts Predict a 56.41% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know
- Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
- PepsiCo, Delta Air Lines To Report Earnings; FOMC's Minutes Of The Meeting In Focus
- Nuvectis: 'Hold' On NXP800 Removal And Newly Licensed Candidates (NASDAQ:NVCT)
- What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now?
- Biotech Is The Rate Cut Trade In Disguise
- What Makes Nuvectis Pharma (NVCT) a New Buy Stock
- Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending - Nuvectis Pharma (NASDAQ:N
- Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Mediated Diseases and Oncology Prepared Remarks Transcript
- Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet
- Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade
- Nuvectis initiates phase 1b trial combining NXP900 with osimertinib
Frequently Asked Questions
What is NVCT stock price today?
Nuvectis Pharma Inc stock is priced at 21.39 today. It trades within 20.29 - 22.23, yesterday's close was 21.92, and trading volume reached 399. The live price chart of NVCT shows these updates.
Does Nuvectis Pharma Inc stock pay dividends?
Nuvectis Pharma Inc is currently valued at 21.39. Dividend policy depends on the company, while investors also watch 218.78% and USD. View the chart live to track NVCT movements.
How to buy NVCT stock?
You can buy Nuvectis Pharma Inc shares at the current price of 21.39. Orders are usually placed near 21.39 or 21.69, while 399 and -2.77% show market activity. Follow NVCT updates on the live chart today.
How to invest into NVCT stock?
Investing in Nuvectis Pharma Inc involves considering the yearly range 5.55 - 29.27 and current price 21.39. Many compare 0.28% and 150.18% before placing orders at 21.39 or 21.69. Explore the NVCT price chart live with daily changes.
What are Nuvectis Pharma Inc stock highest prices?
The highest price of Nuvectis Pharma Inc in the past year was 29.27. Within 5.55 - 29.27, the stock fluctuated notably, and comparing with 21.92 helps spot resistance levels. Track Nuvectis Pharma Inc performance using the live chart.
What are Nuvectis Pharma Inc stock lowest prices?
The lowest price of Nuvectis Pharma Inc (NVCT) over the year was 5.55. Comparing it with the current 21.39 and 5.55 - 29.27 shows potential long-term entry points. Watch NVCT moves on the chart live for more details.
When did NVCT stock split?
Nuvectis Pharma Inc has gone through stock splits historically. These changes are visible in , 21.92, and 218.78% after corporate actions.
- Previous Close
- 21.92
- Open
- 22.00
- Bid
- 21.39
- Ask
- 21.69
- Low
- 20.29
- High
- 22.23
- Volume
- 399
- Daily Change
- -2.42%
- Month Change
- 0.28%
- 6 Months Change
- 150.18%
- Year Change
- 218.78%
- Act
- $-105.572 B
- Fcst
- $-81.515 B
- Prev
- $-92.826 B
- Act
- $315.182 B
- Fcst
- Prev
- $310.723 B
- Act
- $420.754 B
- Fcst
- Prev
- $403.550 B
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- 4.474%